Medicalsystem Biotechnology Co., Ltd (SHE:300439)

China · Delayed Price · Currency is CNY

10.21

-0.10 (-0.97%)

Oct 12, 2026, 3:04 PM CST

Market Cap	3.92B -1.0%
Revenue (ttm)	1.63B +6.6%
Net Income	68.32M -49.9%
EPS	0.17 -51.2%
Shares Out	384.32M
PE Ratio	59.63
Forward PE	n/a
Dividend	0.03 (0.32%)
Ex-Dividend Date	Jun 11, 2026

Volume	3,768,500
Open	10.31
Previous Close	10.31
Day's Range	10.09 - 10.38
52-Week Range	7.83 - 11.11
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2003

Employees 1,936

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300439

Full Company Profile

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.

Financial Statements